FREE Account Opening + No Clearing Fees
Loading...

Akums Drugs and Pharmaceuticals IPO vs Brainbees Solutions (Firstcry) IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Brainbees Solutions (Firstcry) IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Brainbees Solutions (Firstcry) IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Brainbees Solutions (Firstcry) IPO is up to ₹4,193.73 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Brainbees Solutions (Firstcry) IPO is ₹465.00 per share.

  Akums Drugs and Pharmaceuticals IPO Brainbees Solutions (Firstcry) IPO
Face Value ₹2 per share ₹2 per share
Issue Price (Lower) ₹646.00 per share ₹440.00 per share
Issue Price (Upper) ₹679.00 per share ₹465.00 per share
Issue Price (Final) ₹679.00 per share ₹465.00 per share
Discount (Retail)
Discount (Employee) ₹64.00 per share ₹44.00 per share
Market Lot Size 22 shares 32 shares
Fresh Issue Size 1,00,14,727 shares 3,58,27,957 shares
Fresh Issue Size (Amount) up to ₹680.00 Cr up to ₹1,666.00 Cr
OFS Issue Size 1,73,30,435 shares 5,43,59,733 shares
OFS Issue Size (Amount) up to ₹1,176.74 Cr up to ₹2,527.73 Cr
Issue Size Total 2,73,45,162 shares 9,01,87,690 shares
Issue Size Total (Amount) up to ₹1,856.74 Cr up to ₹4,193.73 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Brainbees Solutions (Firstcry) IPO opens on Aug 06, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Brainbees Solutions (Firstcry) IPO is Aug 01, 2024, and Aug 08, 2024, respectively.

  Akums Drugs and Pharmaceuticals IPO Brainbees Solutions (Firstcry) IPO
Anchor Bid Date Jul 29, 2024 Aug 05, 2024
Issue Open Jul 30, 2024 Aug 06, 2024
Issue Close Aug 01, 2024 Aug 08, 2024
Basis Of Allotment (Tentative) Aug 02, 2024 Aug 09, 2024
Initiation of Refunds (Tentative) Aug 05, 2024 Aug 12, 2024
Credit of Share (Tentative) Aug 05, 2024 Aug 12, 2024
Listing date (Tentative) Aug 06, 2024 Aug 13, 2024
Anchor Lockin End date 1 Sep 01, 2024 Sep 08, 2024
Anchor Lockin End date 2 Oct 31, 2024 Nov 07, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Brainbees Solutions (Firstcry) IPO P/E ratio of -69.91.

  Akums Drugs and Pharmaceuticals IPO Brainbees Solutions (Firstcry) IPO
Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets3,516.373,266.533,069.05
Revenue4,212.213,700.933,694.52
Profit After Tax0.7997.82-250.87
Net Worth709.50717.19621.98
Reserves and Surplus861.01868.70787.79
Total Borrowing491.56536.97357.95
Amount in ₹ Crore

Brainbees Solutions Limited Financial Information (Restated Consolidated)

Brainbees Solutions Limited's revenue increased by 14.72% and profit after tax (PAT) rose by 33.85% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets7,510.387,119.836,197.16
Revenue6,575.085,731.282,516.92
Profit After Tax-321.51-486.06-78.69
Net Worth3,170.743,456.263,527.94
Reserves and Surplus3,081.743,367.213,439.17
Total Borrowing462.72176.4790.16
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 84.94%
Promoter Shareholding (Post-Issue)
P/E Ratio -69.91
Market Cap ₹24141.75 Cr.
ROE 0.11%%
ROCE 3.37%%
Debt/Equity 0.69
EPS ₹-6.65
RoNW -0.57% -8.65%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Brainbees Solutions (Firstcry) IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 2,70,36,953 shares in Brainbees Solutions (Firstcry) IPO.

  Akums Drugs and Pharmaceuticals IPO Brainbees Solutions (Firstcry) IPO
Anchor Investor Reserveration 1,22,05,912 shares 4,05,55,428 shares
Market Maker Reserveration
QIB 81,37,276 shares 2,70,36,953 shares
NII 40,68,637 shares 1,35,18,476 shares
RII 27,12,424 shares 90,12,317 shares
Employee 2,43,902 shares 71,258 shares
Others
Total 1,51,62,239 shares 4,96,39,004 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Brainbees Solutions (Firstcry) IPO subscribed 12.22x.

  Akums Drugs and Pharmaceuticals IPO Brainbees Solutions (Firstcry) IPO
QIB (times) 90.09x 19.30x
NII (times) 42.10x 4.68x
Big NII (times) 47.43x 5.32x
Small NII (times) 31.45x 3.39x
RII (times) 20.80x 2.31x
Employee (times) 4.14x 6.57x
Other (times)
Total (times) 63.44x 12.22x

Comments

Add a public comment...